Yale Jen
Stock Analyst at Laidlaw & Co.
(0.10)
# 4,158
Out of 4,761 analysts
13
Total ratings
16.67%
Success rate
-48.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFWD Lifeward | Initiates: Buy | $10 | $1.77 | +466.57% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $8.08 | +494.06% | 1 | Jul 29, 2024 | |
| MEIP MEI Pharma | Downgrades: Hold | n/a | $2.60 | - | 1 | Jul 23, 2024 | |
| AFMD Affimed | Maintains: Buy | $15 → $25 | $1.04 | +2,303.85% | 1 | Jun 13, 2024 | |
| PHGE BiomX | Initiates: Buy | $25 | $0.96 | +2,507.43% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $7.5 | $0.27 | +2,662.43% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $4.27 | - | 2 | Dec 22, 2023 | |
| SILO Silo Pharma | Initiates: Buy | $10 | $1.35 | +640.74% | 1 | Aug 28, 2023 | |
| TCRT Alaunos Therapeutics | Downgrades: Hold | n/a | $1.68 | - | 1 | Aug 15, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $240 | $1.95 | +12,207.69% | 1 | Sep 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $600 | $1.24 | +48,287.10% | 1 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $46.13 | - | 1 | Dec 23, 2019 |
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $1.77
Upside: +466.57%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $8.08
Upside: +494.06%
MEI Pharma
Jul 23, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.60
Upside: -
Affimed
Jun 13, 2024
Maintains: Buy
Price Target: $15 → $25
Current: $1.04
Upside: +2,303.85%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.96
Upside: +2,507.43%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $7.5
Current: $0.27
Upside: +2,662.43%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.27
Upside: -
Silo Pharma
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $1.35
Upside: +640.74%
Alaunos Therapeutics
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.68
Upside: -
NLS Pharmaceutics AG
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $1.95
Upside: +12,207.69%
Sep 13, 2021
Initiates: Buy
Price Target: $600
Current: $1.24
Upside: +48,287.10%
Dec 23, 2019
Initiates: Buy
Price Target: n/a
Current: $46.13
Upside: -